{
  "id": "acc_aha_hf_staging",
  "title": "ACC/AHA Heart Failure Staging",
  "description": "Describes heart failure stages and provides stage-specific therapy recommendations, based on ACC/AHA/HFSA guidelines",
  "category": "cardiology",
  "version": "2022",
  "parameters": [
    {
      "name": "risk_factors",
      "type": "string",
      "required": true,
      "description": "Presence of risk factors for heart failure",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "structural_disease",
      "type": "string",
      "required": true,
      "description": "Evidence of structural heart disease or elevated biomarkers",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "current_symptoms",
      "type": "string",
      "required": true,
      "description": "Current or previous symptoms of heart failure",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "advanced_symptoms",
      "type": "string",
      "required": true,
      "description": "Severe symptoms refractory to optimized treatment",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "hospitalization_frequency",
      "type": "string",
      "required": true,
      "description": "Recurrent hospitalizations for heart failure",
      "options": ["frequent", "rare", "none"],
      "validation": {
        "enum": ["frequent", "rare", "none"]
      }
    },
    {
      "name": "ejection_fraction",
      "type": "float",
      "required": false,
      "description": "Left ventricular ejection fraction (%)",
      "validation": {
        "min": 0.0,
        "max": 100.0
      },
      "unit": "%"
    }
  ],
  "result": {
    "name": "hf_stage",
    "type": "string",
    "unit": "stage",
    "description": "ACC/AHA heart failure stage (A, B, C or D)"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 0,
        "stage": "Stage A",
        "description": "At risk for heart failure",
        "interpretation": "Patients with risk factors but no structural disease or symptoms. Recommendations: hypertension and dyslipidemia control, ACEI/ARB, lifestyle modifications, SGLT2i in diabetics. Goal: prevent HF development."
      },
      {
        "min": 1,
        "max": 1,
        "stage": "Stage B",
        "description": "Pre-heart failure",
        "interpretation": "Structural disease without symptoms. Recommendations: ACEI/ARB, beta-blockers, statins, ICD if indicated (LVEF ≤30% post-MI). Goal: prevent progression to symptomatic HF."
      },
      {
        "min": 2,
        "max": 2,
        "stage": "Stage C",
        "description": "Symptomatic heart failure",
        "interpretation": "Structural disease with current/previous symptoms. Recommendations: ACEI/ARB, beta-blockers, diuretics, aldosterone antagonists (LVEF ≤35%), supervised exercise, sodium restriction. Goal: symptom control and hospitalization prevention."
      },
      {
        "min": 3,
        "max": 3,
        "stage": "Stage D",
        "description": "Advanced heart failure",
        "interpretation": "Refractory severe symptoms. Recommendations: specialized HF team, evaluation for advanced therapies (VAD, transplant), palliative care, palliative inotropes. Goal: symptom improvement and quality of life."
      }
    ]
  },
  "references": [
    "Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032.",
    "Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation. 2005;112(12):e154-235."
  ],
  "formula": "Classification based on presence of risk factors, structural disease, symptoms, and severity",
  "notes": [
    "Unidirectional progression - patients cannot regress to previous stages",
    "Different from NYHA functional classification",
    "Stage C uses additional NYHA classification for symptoms",
    "Based on ACC/AHA/HFSA 2022 guidelines"
  ]
}
